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Abstract. Ambient air pollution from ground-level ozone
and fine particulate matter (PM2.5) is associated with prema-
ture mortality. Future concentrations of these air pollutants
will be driven by natural and anthropogenic emissions and
by climate change. Using anthropogenic and biomass burn-
ing emissions projected in the four Representative Concen-
tration Pathway scenarios (RCPs), the ACCMIP ensemble
of chemistry–climate models simulated future concentrations
of ozone and PM2.5 at selected decades between 2000 and
2100. We use output from the ACCMIP ensemble, together
with projections of future population and baseline mortal-
ity rates, to quantify the human premature mortality impacts
of future ambient air pollution. Future air-pollution-related
premature mortality in 2030, 2050 and 2100 is estimated for
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each scenario and for each model using a health impact func-
tion based on changes in concentrations of ozone and PM2.5
relative to 2000 and projected future population and baseline
mortality rates. Additionally, the global mortality burden of
ozone and PM2.5 in 2000 and each future period is estimated
relative to 1850 concentrations, using present-day and future
population and baseline mortality rates. The change in fu-
ture ozone concentrations relative to 2000 is associated with
excess global premature mortality in some scenarios/periods,
particularly in RCP8.5 in 2100 (316 thousand deaths year−1),
likely driven by the large increase in methane emissions and
by the net effect of climate change projected in this scenario,
but it leads to considerable avoided premature mortality for
the three other RCPs. However, the global mortality bur-
den of ozone markedly increases from 382 000 (121 000 to
728 000) deaths year−1 in 2000 to between 1.09 and 2.36 mil-
lion deaths year−1 in 2100, across RCPs, mostly due to the
effect of increases in population and baseline mortality rates.
PM2.5 concentrations decrease relative to 2000 in all scenar-
ios, due to projected reductions in emissions, and are associ-
ated with avoided premature mortality, particularly in 2100:
between −2.39 and −1.31 million deaths year−1 for the four
RCPs. The global mortality burden of PM2.5 is estimated
to decrease from 1.70 (1.30 to 2.10) million deaths year−1
in 2000 to between 0.95 and 1.55 million deaths year−1 in
2100 for the four RCPs due to the combined effect of de-
creases in PM2.5 concentrations and changes in population
and baseline mortality rates. Trends in future air-pollution-
related mortality vary regionally across scenarios, reflecting
assumptions for economic growth and air pollution control
specific to each RCP and region. Mortality estimates differ
among chemistry–climate models due to differences in sim-
ulated pollutant concentrations, which is the greatest contrib-
utor to overall mortality uncertainty for most cases assessed
here, supporting the use of model ensembles to character-
ize uncertainty. Increases in exposed population and base-
line mortality rates of respiratory diseases magnify the im-
pact on premature mortality of changes in future air pollutant
concentrations and explain why the future global mortality
burden of air pollution can exceed the current burden, even
where air pollutant concentrations decrease.
1 Introduction
Ambient air pollution has adverse effects on human health,
including premature mortality. Exposure to ground-level
ozone is associated with respiratory mortality (e.g., Bell et
al., 2005; Gryparis et al., 2004; Jerrett et al., 2009; Levy et
al., 2005). Exposure to fine particulate matter with aerody-
namic diameter less than 2.5 µm (PM2.5) is associated with
mortality due to cardiopulmonary diseases and lung can-
cer (e.g., Brook et al., 2010; Burnett et al., 2014; Hamra et
al., 2014; Krewski et al., 2009; Lepeule et al., 2012). Pre-
vious studies have estimated the present-day global burden
of disease due to exposure to ambient ozone and/or PM2.5
(e.g., Apte et al., 2015; Evans et al., 2013; Forouzanfar et
al., 2015), with several studies estimating this burden using
only output of global atmospheric models (Anenberg et al.,
2010; Fang et al., 2013a; Lelieveld et al., 2013; Rao et al.,
2012; Silva et al., 2013). However, few studies have eval-
uated how the global burden might change in future sce-
narios (Lelieveld et al., 2015; Likhvar et al., 2015; West et
al., 2007). Other global studies have estimated future air-
pollution-related mortality as a by-product of analyses of
other future changes, such as the effects of climate change or
of climate change mitigation (e.g., Fang et al., 2013b; Selin
et al., 2009; West et al., 2013), but do not focus on the range
of plausible future mortality as their main purpose. Similarly,
studies at local and regional scales have evaluated the mor-
tality impact of changes in air quality due to future climate
change (Bell et al., 2007; Chang et al., 2010; Fann et al.,
2015; Heal et al., 2012; Jackson et al., 2010; Knowlton et
al., 2004, 2008; Orru et al., 2013; Post et al., 2012; Sheffield
et al., 2011; Tagaris et al., 2009) but few such studies have
evaluated changes beyond 2050.
Future ambient air quality will be influenced by changes in
emissions of air pollutants and by climate change. Changes
in anthropogenic emissions will likely dominate in the near-
term (Kirtman et al., 2013, and references therein) and de-
pend on several socioeconomic factors including economic
growth, energy demand, technological choices and devel-
opments, demographic trends and land use change, as well
as air quality and climate policies. Climate change will
affect the ventilation, dilution and removal of air pollu-
tants, the frequency of stagnation, photochemical reaction
rates, stratosphere–troposphere exchange of ozone and nat-
ural emissions (Fiore et al., 2012, 2015; Jacob and Winner,
2009; von Schneidemesser et al., 2015; Weaver et al., 2009).
Climate change is likely to increase ozone in polluted regions
during the warm season, particularly in urban areas and dur-
ing pollution episodes. In remote regions, however, ozone is
likely to decrease due to greater water vapor concentrations,
which increase the loss of ozone by photolysis and subse-
quent formation of hydroxyl radicals (Doherty et al, 2013).
The effects of climate change on PM2.5 concentrations are
generally uncertain as changes in temperature affect both re-
action rates and gas to particle partitioning, as well as wild-
fires and biogenic emissions, and vary regionally primarily
due to differing projections of changes in precipitation (Fiore
et al., 2012, 2015; Fuzzi et al., 2015; Jacob and Winner, 2009;
von Schneidemesser et al., 2015; Weaver et al., 2009).
The Atmospheric Chemistry and Climate Model In-
tercomparison Project (ACCMIP) simulated preindustrial
(1850), present-day (2000) and future (2030, 2050 and 2100)
concentrations of ozone and PM2.5 with an ensemble of
14 state-of-the-art chemistry climate models (Table S1 in
the Supplement) (Lamarque et al., 2013; Stevenson et al.,
2013) to support the IPCC’s Fifth Assessment Report. Using
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modeled 1850 and 2000 concentrations from this ensemble,
we showed previously that exposure to present-day anthro-
pogenic ambient air pollution is associated with 470 (95 %
confidence interval (CI): 140, 900) thousand deaths year−1
from ozone-related respiratory diseases and 2.1 (1.3, 3.0)
million deaths year−1 from PM2.5-related cardiopulmonary
diseases and lung cancer (Silva et al., 2013). These results
were obtained for a wider range of cardiopulmonary diseases
and using a different exposure–response model for PM2.5
mortality than the present study, as discussed later.
The ACCMIP models simulated future air quality for spe-
cific periods through 2100, for four global greenhouse gas
(GHG) and air pollutant emission scenarios projected in the
Representative Concentration Pathways (RCPs) (Van Vuuren
et al., 2011a, and references therein). The four RCPs were de-
veloped by different research groups with different assump-
tions regarding the pathways of population growth, economic
and technological development, and air quality and climate
policies. Anthropogenic radiative forcing in 2100 ranges
from a very low level in the mitigation scenario RCP2.6 (Van
Vuuren et al., 2011b), to medium levels in the two stabiliza-
tion scenarios, RCP4.5 (Thomson et al., 2011) and RCP 6.0
(Masui et al., 2011), to a high level in the very high baseline
emissions scenario RCP8.5 (Riahi et al., 2011). All RCPs
assume increasingly stringent air pollution controls as coun-
tries develop economically, leading to decreases in air pollu-
tant emissions that reflect the different methods of the dif-
ferent RCP groups (e.g., Smith et al., 2011). However, as
assumptions are similar among the RCPs, the four scenar-
ios do not span the range of possible futures published in
the literature for short-term species. For example, other stud-
ies have simulated scenarios in which air pollution controls
are kept at current levels while underlying trends (e.g., en-
ergy use) increase overall emissions (Lelieveld et al., 2015;
Likhvar et al., 2015). While most air pollutants are projected
to decrease, ammonia increases in all RCPs due to the pro-
jected increase in population and food demand, and methane
increases in RCP8.5 because of its projected rise in livestock
and rice production. However, these scenarios follow differ-
ent pathways in different regions. In some regions, emissions
increase to mid-century before decreasing, while in other re-
gions emissions are already decreasing at present and con-
tinue decreasing to 2100. Models in the ACCMIP ensemble
incorporate chemistry–climate interactions, including mech-
anisms by which climate change affects ozone and PM2.5,
although models do not all include the same mechanisms of
interactions and do not always agree on the net effect of these
interactions (von Schneidemesser et al., 2015).
Using modeled ozone and PM2.5 concentrations from the
ACCMIP ensemble, we estimate the future premature hu-
man mortality associated with exposure to ambient air pol-
lution. Our premature mortality estimates are obtained using
a health impact function, combining the relative risk of ex-
posure to changes in air pollution with future exposed pop-
ulation and cause-specific baseline mortality rates. We esti-
mate overall future premature mortality considering the dif-
ference in air pollution associated with 2030, 2050 and 2100
emissions and climate relative to that resulting from 2000
emissions and climate. Mortality estimates are obtained at
a sufficiently fine horizontal resolution (0.5◦× 0.5◦) to cap-
ture both global and regional effects and inform regional and
national air quality and climate change policy but are not ex-
pected to capture local scale (e.g., urban) air pollution effects.
2 Methods
2.1 Ambient ozone and PM2.5 concentrations
Concentrations of ozone and PM2.5 in surface air are calcu-
lated for the present day (2000) and for the 2030, 2050 and
2100 decades for the four RCPs using the output of simula-
tions by the ACCMIP ensemble of chemistry–climate mod-
els. As described by Lamarque et al. (2013), not all models
are truly coupled chemistry–climate models. OsloCTM2 and
MOCAGE are chemical transport models driven by offline
meteorological fields, and UM-CAM and STOC-HadAM3
do not model the feedback of chemistry on climate.
All ACCMIP models used nearly identical anthropogenic
and biomass burning emissions for the present day and fu-
ture, but they used different natural emissions (e.g., biogenic
volatile organic compounds, ocean emissions, soil and light-
ning NOx), which mostly impacted emissions of ozone pre-
cursors (Lamarque et al., 2013; Young et al., 2013) and natu-
ral aerosols (i.e., dust and sea salt). Model output shows good
agreement with recent observations, both for ozone (Young
et al., 2013) and for PM2.5 (Shindell et al., 2013), although
models tend to overestimate ozone in the Northern Hemi-
sphere and underestimate it in the Southern Hemisphere and
to underestimate PM2.5, particularly in East Asia. Future sur-
face concentrations of air pollutants vary across scenarios
and models, but ozone is projected to decrease except in
RCP8.5, mostly associated with the large increase in methane
concentrations specific to this scenario and the effect of cli-
mate change in remote regions (von Schneidemesser et al.,
2015; Young et al., 2013).
We obtained hourly and monthly output from the ACCMIP
ensemble simulations for a base year (2000) and for future
projections under the four RCPs (2030, 2050 and 2100),
with each time period corresponding to simulations of up
to 10 years, depending on the model. Only two models re-
ported results for all four RCP scenarios and the three fu-
ture time periods – GFDL-AM3 and GISS-E2-R. PM2.5 is
calculated as a sum of aerosol species reported by six mod-
els (see Supplement), and four of these models also reported
their own estimate of total PM2.5 (Table S1 in the Supple-
ment). Our PM2.5 formula includes nitrate; since this species
was reported by three models only, we calculate the average
nitrate concentrations in each cell reported by these models
and add this average to PM2.5 for the other models, follow-
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ing Silva et al. (2013). We use our PM2.5 estimates to obtain
all mortality results and perform a sensitivity analysis using
the PM2.5 concentrations reported by four models using their
own PM2.5 formulas, which differed among models, as done
by Silva et al. (2013). The native grid resolutions of the 14
models varied from 1.9◦× 1.2◦ to 5◦× 5◦; we regrid ozone
and PM2.5 species surface concentrations from each model
to a common 0.5◦× 0.5◦ horizontal grid to take maximum
advantage of how the grids of different models overlap, fol-
lowing Anenberg et al. (2009, 2014) and Silva et al. (2013).
Ozone and PM2.5 concentrations are calculated in each
grid cell for each model separately. For both pollutants, we
use identical metrics to those reported in the epidemiological
studies we considered for the health impact assessment (next
section):
– seasonal average of daily 1 h maximum ozone concen-
tration, for the 6 consecutive months with highest con-
centrations in each grid cell;
– annual average PM2.5 concentration.
Among the 14 models, 5 models reported only monthly
ozone concentrations, while the remaining models reported
both hourly and monthly values. We calculate the ratio of the
seasonal average of daily 1 h maximum to the annual average
of monthly concentrations, for each scenario/year, for those
that reported both hourly and monthly concentrations. Then
we apply that ratio to the annual average of monthly ozone
concentrations for the former five models, as previously done
by Silva et al. (2013). The differences in ozone and PM2.5
concentrations between future year (2030, 2050 and 2100)
and 2000 are shown in Tables S2 and S3, for each model. For
10 world regions (Fig. S1 in the Supplement), we also es-
timate regional multi-model averages for each scenario/year
(Figs. S2 and S3).
2.2 Health impact assessment
We estimate future air-pollution-related cause-specific pre-
mature mortality using generally the same methods as those
used by Silva et al. (2013) to obtain present-day estimates,
but with two important differences: (1) we use the recently
published Integrated Exposure–Response (IER) model for
PM2.5 (Burnett et al., 2014) instead of a log-linear model
(Krewski et al., 2009), and (2) we use projections of popu-
lation and baseline mortality rates from the International Fu-
tures (IFs) integrated modeling system (Hughes et al., 2011).
We apply a health impact function to estimate premature
mortality associated with exposure to ozone and PM2.5 am-
bient air pollution (1Mort) in each grid cell: 1Mort= y0×
AF×Pop, where y0 is the baseline mortality rate (for the ex-
posed population), AF= 1−1/RR is the attributable fraction,
RR is the relative risk of death attributable to a change in pol-
lutant concentrations (RR= 1 if there is no increased risk of
death associated with a change in pollutant concentrations)
and Pop is the exposed population (adults aged 25 and older).
We calculate changes in premature mortality by applying
the change in pollutant concentrations in each future year
(2030, 2050 and 2100) relative to year 2000 concentrations
– the present-day state of air pollution – to the future popu-
lation. To estimate ozone mortality, we apply the exposure–
response function to the difference in ozone concentrations,
while for PM2.5 mortality we apply the exposure–response
function to concentrations in each year (future years and
2000) and then subtract the mortality estimates. We there-
fore estimate “avoided”/“excess” premature mortality due to
decreases/increases in air pollutant concentrations in the fu-
ture years relative to 2000 concentrations. This approach dif-
fers from a calculation of the global burden of air-pollution-
related mortality since we use 2000 rather than 1850 con-
centrations as baseline. We estimate mortality changes due
to future concentration changes, relative to the present, to
avoid applying the health impact function at very low con-
centrations where there is less confidence in the exposure–
response relationship. For example, the simulated 1850 air
pollutant concentrations are often below the lowest measured
value of the American Cancer Society study (Jerrett et al.,
2009; Krewski et al., 2009). For illustration, we also esti-
mate mortality relative to 1850 concentrations, which could
be regarded as global burden of disease calculations, follow-
ing Silva et al. (2013).
For each model, we estimate ozone-related mortality due
to chronic respiratory diseases (RESP), using RR from Jer-
rett et al. (2009). We also estimate PM2.5-related mortality
due to ischemic heart disease (IHD), cerebrovascular disease
(STROKE), chronic obstructive pulmonary disease (COPD)
and lung cancer (LC), using RRs from the IER model (Bur-
nett et al., 2014). We use RR per age group for IHD and
STROKE and RR for all ages for COPD and LC. We apply
the IER model instead of RRs from Krewski et al. (2009),
used by Silva et al. (2013), as the newer model should better
represent the risk of exposure to PM2.5, particularly at loca-
tions with high ambient concentrations. In the IER model, the
concentration–response function flattens off at higher PM2.5
concentrations yielding different estimates of excess mortal-
ity for identical changes in air pollutant concentrations in
less-polluted vs. highly polluted locations. Specifically, a one
unit reduction of air pollution may have a stronger effect on
avoided mortality per million people in regions where pollu-
tion levels are lower (e.g., Europe, North America) compared
with highly polluted areas (e.g., East Asia, India), which
would not be the case for a log-linear function (Jerrett et al.,
2009; Krewski et al., 2009). Therefore, using the IER model
may result in smaller changes in avoided mortality in highly
polluted areas than using the log-linear model.
Each RCP includes its own projection of total popula-
tion but not population health characteristics. For all sce-
narios, we choose to use a common projection of popula-
tion and baseline mortality rates per age group from the IFs
(Figs. S6 and S7). IFs project population and mortality based
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on UN and WHO projections from 2010 through 2100, per
age group and country, mostly based on three drivers – in-
come, education and technology (Hughes et al., 2011). Popu-
lation projections from IFs differ from those underlying each
RCP but lie within the range of the RCPs (Fig. S6). In 2030,
global total population in IFs is within 0.08 % of that re-
ported for RCP2.6, RCP4.5 and RCP6.0 and 5 % lower than
for RCP8.5; however, in 2100 IFs project larger global pop-
ulations than RCP2.6 (+7 %), RCP4.5 (+13 %) and RCP6.0
(+2 %) and considerably lower than RCP8.5 (−27 %). IFs
project rising baseline mortality rates for cardiovascular dis-
eases (CVD) and RESP, globally and in most regions (partic-
ularly in East Asia and India), reflecting an aging population.
By using projections from IFs, we have a single source of
population and baseline mortality rates, assuring their con-
sistency and enabling us to isolate the effect of changes in
air pollutant concentrations across the RCPs. Had we used
the population projections from each scenario, the magni-
tude of the changes (increases or decreases in premature mor-
tality relative to 2000) would likely increase in RCP8.5 but
decrease in RCP2.6, RCP4.5 and RCP6.0. With the excep-
tion of Europe, Former Soviet Union (FSU) and East Asia,
where population is projected to decrease in 2100 relative
to 2000, had we used present-day population and baseline
mortality we would have obtained lower estimates for ex-
cess or avoided mortality in each scenario/year, as projected
increases in population and baseline mortality magnify the
impact of changes in air pollutant concentrations. Therefore,
we estimate the overall effect of future air pollution (due to
changes in emissions and climate change) considering the
population that will potentially be exposed to those effects.
We also obtain different estimates of changes in future mor-
tality than if we had calculated the global burden in each year,
using air pollutant concentrations, population and baseline
mortality rates in that year and subtracted the present-day
burden. Our results do not reflect the potential synergistic
effect of a warmer climate on air-pollution-related mortality,
i.e., we do not account for potential changes in the exposure–
response relationships at higher temperatures (Pattenden et
al., 2010; Wilson et al., 2014, and references therein).
Country-level population projections for 2030, 2050 and
2100 are gridded to 0.5◦× 0.5◦ using ArcGIS 10.2 geopro-
cessing tools, assuming that the spatial distribution of total
population within each country is unchanged from the 2011
LandScan Global Population Dataset at approximately 1 km
resolution (Bright et al., 2012) and that the exposed pop-
ulation is distributed in the same way as the total popula-
tion within each country. IFs projections of mortality rates
for CVD are used to estimate baseline mortality rates for
IHD and STROKE considering their present-day proportion
in CVD (using GBD 2010 baseline mortality rates), as are
RESP projections for COPD and malignant neoplasms for
LC. IFs projections for 2010 are comparable to GBD 2010
(Lozano et al., 2012) estimates for CVD (+0.04 %), RESP
(+2.5 %) and neoplasms (−12 %). We estimate the number
of deaths per 5-year age group per country using the country
level population. The resulting population and baseline mor-
tality per age group at 30 s× 30 s are regridded to the same
0.5◦× 0.5◦ grid as the concentrations of air pollutants.
Uncertainty from the RRs is propagated separately for
each model/scenario/year to mortality estimates in each grid
cell, through 1000 Monte Carlo (MC) simulations; i.e., we
repeat the calculations in each grid cell 1000 times using ran-
dom sampling of the RR variable. For ozone, we use the re-
ported 95 % CIs for RR (Jerrett et al., 2009) and assume a
normal distribution, while for PM2.5 we use the values for
the parameters alpha, gamma, delta and zcf (counterfactual)
reported by Burnett et al. (2014) for 1000 MC simulations
(GHDx, 2013). Then for each of the 1000 simulations, we
add mortality over many grid cells to obtain regional and
global mortality and estimate the empirical mean and 95 %
CI of the regional and global mortality results. We assume no
correlation between the RRs for the four causes of death; thus
we may underestimate the overall uncertainty for PM2.5 mor-
tality estimates. Uncertainty in air pollutant concentrations is
based on the spread of model results by calculating the av-
erage and 95 % CI for the pooled results of the 1000 MC
simulations for each model. This estimate of uncertainty in
concentrations does not account for uncertainty in emissions
inventories (as the ensemble used identical emissions) or for
potential bias in modeled air pollutant concentrations. We
also estimate the contribution of uncertainties in RR and in
air pollutant concentrations to the overall uncertainty in mor-
tality estimates using a tornado analysis; we obtained global
mortality estimates treating each variable as uncertain indi-
vidually (year 2000 concentrations, future year concentra-
tions, RR for ozone and the four parameters in the IER model
for PM2.5) and used central estimates for all other variables,
and then we calculated the contribution of each variable to
the overall uncertainty (when all variables are treated as un-
certain simultaneously). Uncertainties associated with popu-
lation and baseline mortality rates are not reported by IFs and
are not considered in the uncertainty analysis.
3 Results
First, we present our estimates of ozone and PM2.5-related
excess / avoided premature mortality in 2030, 2050 and 2100
for changes in pollutant concentrations between 2000 and
each future period, for the four RCPs (Sects. 3.1 and 3.2,
Figs. 1 to 7). Figures 1 and 4 show global mortality for the
different ACCMIP models. The multi-model average mortal-
ity results are shown for individual grid cells (Figs. 2 and 5)
and for regional totals (Figs. 3 and 6). Finally, we include
our estimates of the global mortality burden of both air pol-
lutants for future concentrations relative to 1850 concentra-
tions (Sect. 3.3, Figs. 8 and 9). In some cases, the changes in
future mortality due to changes in future concentrations rel-
ative to 2000 show a different trend than the global mortality
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Figure 1. Estimates of future ozone respiratory mortality for all RCP scenarios in 2030, 2050 and 2100, showing global mortality for 13
models and the multi-model average (million deaths year−1), for future air pollutant concentrations relative to 2000 concentrations. Uncer-
tainty for the multi-model average shown for RCP8.5 is the 95 % CI, including uncertainty in RR and across models. Only models with
results for the 3 years have lines connecting the markers.
burden; this difference reflects the combined effects of future
changes in concentrations relative to 1850, exposed popula-
tion and baseline mortality rates.
3.1 Ozone-related future premature mortality
We find that future changes in ozone concentrations are as-
sociated with excess global premature mortality due to respi-
ratory diseases in 2030 but avoided mortality by 2100 for all
scenarios but RCP8.5 (Fig. 1, Table S5). In 2030, all RCPs
show excess multi-model average ozone mortality, ranging
from 11 900 (RCP2.6) to 264 000 (RCP8.5) deaths year−1.
For each RCP, however, some models yield avoided mor-
tality in 2030. In 2050, multi-model averages are obtained
from only three or four models, depending on the scenario,
which makes it difficult to compare with the other two peri-
ods. In 2100, we estimate excess ozone mortality in RCP8.5
(316 000 deaths year−1) but avoided ozone mortality for the
other three RCPs from −1.02 million (RCP2.6) to −718 000
(RCP6.0) deaths year−1 with all models agreeing in sign of
the change.
Excess ozone-related future premature mortality (Figs. 2
and 3, Table S6) is noticeable in some regions in 2030 for
all RCPs, particularly in India and East Asia for RCP8.5
(over 95 % of global excess mortality), but all scenarios ex-
cept RCP8.5 show avoided global ozone-related mortality
in 2100. Under this scenario in 2100, there are increases in
ozone concentrations in all regions except North America,
East Asia and Southeast Asia (Fig. S2), likely driven by the
projected large increase in methane emissions as well as by
climate change. Avoided mortality in those three regions is
outweighed by excess mortality in India, Africa and the Mid-
dle East. Also, some regions show different trends in future
mortality relative to 2000 depending on the RCP, reflecting
the effects of distinct assumptions in each RCP about eco-
nomic growth and air pollution control with different trends
in regional ozone precursor emissions. For example, North
America and Europe show decreases in mortality through
2100 in all scenarios, except a slight increase in Europe for
RCP8.5 in 2100. In East Asia, mortality peaks in 2050 for
RCP6.0, driven by peak precursor emissions in 2050 in this
scenario, but peaks in 2030 for the other three RCPs. India
shows peaks in mortality in 2050 followed by decreases for
all RCPs but RCP8.5, in which mortality increases through
2100. Africa shows increases in mortality through 2100 for
RCP2.6 and RCP8.5, while it peaks in 2050 for RCP4.5
and decreases through 2100 for RCP6.0. Also, the effect of
changes in population and baseline mortality rates is notice-
able in some regions when comparing the trends in total
ozone-related mortality and mortality per million people in
each region (Fig. S10). For example, decreases in popula-
tion projected for 2100 in Europe, FSU and East Asia are
reflected in greater changes in mortality per million people
than in total mortality, while the 3-fold increase in popula-
tion in Africa amplifies the changes in total mortality.
For RCP8.5, we propagate input uncertainty to the mortal-
ity estimates (Fig. 1, Table S5). Global future premature mor-
tality changes from 264 000 (−39 300 to 648 000) deaths in
2030 to 316 000 (−187 000 to 1.38 million) deaths in 2100.
Uncertainty in RR leads to coefficients of variation (CV)
ranging from 31 to 37 % (2030), 31 to 40 % (2050) and 16 to
47 % (2100) for the different models. Considering the spread
of model results, overall CV for the multi-model average
mortality increases to 66 % (2030), 78 % (2050) and 125 %
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Figure 2. Future ozone respiratory mortality for all RCP scenarios in 2030, 2050 and 2100, showing the multi-model average in each grid
cell, for future air pollutant concentrations relative to 2000 concentrations.
Figure 3. Future ozone respiratory mortality for all RCP scenarios in 2030, 2050 and 2100, showing the multi-model regional average
(deaths year−1) in 10 world regions (Fig. S1) and globally, for future air pollutant concentrations relative to 2000 concentrations.
(2100). While uncertainty in RR and in modeled ozone con-
centrations have similar contributions to overall uncertainty
in mortality results in 2050 (51 and 49 %, respectively), in
2030 modeled ozone concentrations are the greatest contrib-
utor (81 %), and in 2100 uncertainty in RR contributes the
most to overall uncertainty (88 %). For 2030, HadGEM2 dif-
fers in sign from the other 13 models with (avoided) global
mortality totalling −33 900 deaths year−1. For 2050, LMD-
zORINCA differs substantially from the other three mod-
els with −38 900 deaths year−1. For 2100, HadGEM2 is a
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noticeable outlier with 1.2 million excess deaths year−1 and
MOCAGE differs in sign from the other 12 models with
−159 000 deaths year−1.
3.2 PM2.5-related future premature mortality
Global PM2.5-related premature mortality, considering the
difference in future concentrations and 2000 concentra-
tions, decreases substantially in most scenarios, particu-
larly in 2100 (Fig. 4, Table S7). In 2030, the multi-
model average varies from −289 000 (RCP4.5) to 17 200
(RCP8.5) deaths year−1, although one model (CICERO-
OsloCTM2) shows excess mortality for RCP2.6 and RCP8.5.
In 2050, substantial avoided mortality is estimated for all sce-
narios except RCP6.0, which shows a small increase in mor-
tality (16 700 deaths year−1), but this is the average of only
three models that do not agree on the sign of the change.
In 2100, all scenarios show considerable avoided mortal-
ity, ranging from −1.31 million (RCP8.5) to −2.39 million
(RCP4.5) deaths year−1, reflecting the substantial decrease in
emissions of primary PM2.5 and precursors.
In several regions (North America, South America, Eu-
rope, FSU and Australia), PM2.5 future premature mortal-
ity decreases through 2100 for all RCPs (Figs. 5 and 6,
Table S7). However, in East Asia, Southeast Asia, India,
Africa and the Middle East, for some scenarios, PM2.5 mor-
tality increases through 2030 or 2050 before decreasing. The
changes in future mortality reflect changes in future PM2.5
concentrations relative to 2000 (Fig. S3) and a substantial
increase in exposed population through the 21st century,
particularly in Africa, India and the Middle East (Fig. S6).
That is, any reduction / increase in mortality due to the de-
crease / increase in pollutant concentrations was amplified by
the increases in exposed population. The decreases in popu-
lation in Europe, FSU and East Asia have similar effects as
those mentioned above for ozone-related mortality. For ex-
ample, while total avoided mortality in 2100 in East Asia de-
creases compared to 2050, for RCP2.6, RCP4.5 and RCP8.5,
total avoided mortality per million people increases in the
same scenarios (Fig. S11). East and South Asia are the re-
gions with the greatest projected mortality burdens, and the
variability in PM2.5 among models is typically less in these
regions than in several other regions globally, depending
upon the scenario and year (Fig. S9).
Future PM2.5-related mortality estimates are influenced by
the nonlinearity of the IER function. For example, in RCP8.5
in 2030, all models project an increase in global population-
weighted concentration (Table S3), but all models except one
show decreases in global PM2.5-related mortality (Fig. 4).
This outcome results in part because PM2.5 increases are pro-
jected in regions with high concentrations (particularly East
Asia) that are on the flatter part of the IER curve, whereas
PM2.5 decreases in regions with low concentrations (North
America and Europe) have a steeper slope and therefore a
greater influence on global mortality.
Considering the results of the MC simulations for RCP8.5,
premature mortality changes from −17 200 (−386 000 to
661 000) deaths in 2030 to −1.31 (−2.04 to −0.17) million
deaths in 2100 (Fig. 4, Table S7). Uncertainty in RR leads
to a CV of 11 to 191 % for the different models in the 3
future years. The spread of model results increases overall
CV to 1644 % (2030), 20 % (2050) and 41 % (2100). Uncer-
tainty in modeled PM2.5 concentrations in 2000 is the great-
est contributor to overall uncertainty (59 % in 2030, 45 % in
2050 and 49 % in 2100), followed by uncertainty in modeled
PM2.5 in future years (40 % in 2030, 26 % in 2050 and 32 %
in 2100). Uncertainty in RR has a negligible contribution to
overall uncertainty in 2030 (< 1 %), as the multi-model mean
mortality change happens to be near 0 (one model projects a
large increase while the other five models project decreases)
but contributes 29 % in 2050 and 20 % in 2100.
We compared mortality results using our estimates of
PM2.5 from the sum of reported species with results using
PM2.5 reported by four models applying their own formula
to estimate PM2.5 (Fig. 7). The multi-model average future
avoided mortality for the four models which reported PM2.5
is comparable although lower than the average for our PM2.5
estimates for the same models. Individual models do not
show the same differences in mortality using their own vs.
our PM2.5 estimates. Also, for two models (GFDL-AM3 and
MIROC-CHEM) the two sources of PM2.5 estimates yield
mortality changes of different sign in 2030. These results re-
flect the different aerosol species included by each model to
estimate PM2.5 (e.g., nitrate is not included by all models).
3.3 Global burden on mortality of ozone and PM2.5
Here we present estimates of the global burden on mortal-
ity of ozone and PM2.5 concentrations in the future, consid-
ering the four RCPs relative to preindustrial concentrations
(1850) and future exposed population and baseline mortal-
ity rates (Figs. 8 and 9, Tables S8 and S9). For context, we
estimate the present-day global burden, using 2000 concen-
trations, population from LandScan 2011 Population Dataset
and baseline mortality rates from GBD2010, to be 382 000
(121 000 to 728,000) ozone deaths year−1 and 1.70 (1.30
to 2.10) million PM2.5 deaths year−1. These estimates are
18.7 % lower for ozone-related mortality and 19.1 % lower
for PM2.5-related mortality than those obtained in our previ-
ous study (Silva et al., 2013), reflecting (a) more restrictive
mortality outcomes (chronic respiratory diseases rather than
all respiratory diseases, and IHD+STROKE+COPD rather
than all cardiopulmonary diseases), (b) updated population
and baseline mortality rates and (c) the use of the recent IER
model (Burnett et al., 2014) for PM2.5 (instead of Krewski
et al., 2009). Compared with the GBD 2013 (Forouzan-
far et al., 2015), our estimates are 76 % higher for ozone-
related mortality and 42 % lower for PM2.5-related mortal-
ity, likely due to the fact that we estimate the global mor-
tality burden using 1850 concentrations as baseline, while
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Figure 4. Estimates of future premature mortality (IHD+STROKE+COPD+LC) for PM2.5 calculated as a sum of species, for all RCP
scenarios in 2030, 2050 and 2100, showing global mortality for six models and the multi-model average (million deaths year−1), for future
air pollutant concentrations relative to 2000 concentrations. Uncertainty shown for the RCP8.5 multi-model average is the 95 % CI, including
uncertainty in RR and across models.
Figure 5. Future premature mortality (IHD+STROKE+COPD+LC) for PM2.5 calculated as a sum of species, for all RCP scenarios in 2030,
2050 and 2100, showing the multi-model average in each grid cell, for future air pollutant concentrations relative to 2000 concentrations.
Forouzanfar et al. (2015) consider counterfactual concentra-
tions (theoretical minimum-risk exposure) that are mostly
higher for ozone (uniform distribution between 33.3 and
41.9 ppb) and lower for PM2.5 (uniform distribution between
5.9 and 8.7 µg m−3) than 1850 concentrations. In addition,
we consider ozone mortality from all chronic respiratory
diseases while Forouzanfar et al. (2015) only account for
COPD, and we restrict our mortality estimates to adult pop-
ulation while Forouzanfar et al. (2015) include PM2.5 mor-
tality from lower respiratory tract infections in children un-
der 5 years old. As a sensitivity analysis, when we apply a
counterfactual of 33.3 ppb (instead of using 1850 concentra-
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Figure 6. Future premature mortality (IHD+STROKE+COPD+LC) for PM2.5 calculated as a sum of species, for all RCP scenarios in
2030, 2050 and 2100, showing the multi-model regional average (deaths per year) in 10 world regions (Fig. S1) and globally, for future air
pollutant concentrations relative to 2000 concentrations.
Figure 7. Estimates of global future premature mortality
(IHD+STROKE+COPD+LC) for RCP8.5 in 2030 and 2100, for
PM2.5 reported by four models and PM2.5 estimated as a sum of
species for six models, showing global mortality for each model and
the multi-model average (million deaths year−1), for future air pol-
lutant concentrations relative to 2000 concentrations. Models sig-
naled with * reported their own estimate of PM2.5. Uncertainty
shown for six models for sum of species is the 95 % CI including
uncertainty in RR and across models.
tions), our ozone-related mortality estimates are 23 % higher
for the multi-model mean, varying between +10 and +52 %
among models. Similarly, using the IER model counterfac-
tual, our PM2.5-related mortality estimates are 22 % lower
for the multi-model mean, varying between −8 and −44 %
among models.
For ozone, the global mortality burden increases in
all RCPs through 2050 to between 1.84 and 2.60 mil-
lion deaths year−1, and then it decreases slightly for RCP8.5
Figure 8. Global burden on mortality of ozone concentrations rel-
ative to 1850, in the present day for 2000 concentrations, showing
multi-model average and 95 % CI including uncertainty in RR and
across models (deaths per year), and in 2030, 2050 and 2100 for
all RCPs, showing multi-model averages (deaths per year) given by
the deterministic values. Also shown are future burdens using (Case
A) 2000 concentrations relative to 1850 and present-day population
but future baseline mortality rates and (Case B) 2000 concentrations
relative to 1850 but future population and baseline mortality rates.
and substantially for the other RCPs, ranging between 1.09
and 2.36 million deaths year−1 in 2100. The increase can
be explained by the rise in the baseline mortality rates for
chronic respiratory diseases magnified by the increase in
exposed population, while the decline is likely mostly re-
lated to the decrease in concentrations, slightly countered
by further population growth (Fig. 8). The global burden
of mortality from PM2.5 shows a declining trend for all
RCPs from 2030 to 2100, peaking between 2.4 and 2.6 mil-
lion deaths year−1 in 2030 then declining to between 0.56
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Figure 9. Global burden on mortality of PM2.5 concentrations rel-
ative to 1850, in the present day for 2000 concentrations, showing
multi-model average and 95 % CI including uncertainty in RR and
across models (deaths per year), and in 2030, 2050 and 2100 for
all RCPs, showing multi-model averages (deaths per year) given by
the deterministic values. Also shown are future burdens using (Case
A) 2000 concentrations relative to 1850 and present-day population
but future baseline mortality rates and (Case B) 2000 concentrations
relative to 1850 but future population and baseline mortality rates.
and 1.55 million deaths year−1 in 2100, except for RCP6.0
which peaks in 2050 (3.50 million deaths year−1) before de-
clining considerably. For PM2.5, the increase in exposed pop-
ulation and the decline in concentrations have a much greater
effect than changes in baseline mortality rates (Fig. 9). These
results are similar to those of Apte et al. (2015) who re-
port a stronger effect of projected demographic trends in In-
dia and China in 2030 than of changes in baseline mortal-
ity rates. Our estimates for the global burden of PM2.5 mor-
tality in 2050 (between 1.82 and 3.50 million deaths year−1
for the four RCPs) are considerably lower than those
of Lelieveld et al. (2015) (5.87 million deaths year−1 for
IHD+STROKE+COPD+LC), likely due to the assumption
in the RCP scenarios of further regulations on air pollu-
tants, while the Business-As-Usual scenario of Lelieveld et
al. (2015) does not assume regulations beyond those cur-
rently defined.
To help explain differences between the trends in future
global burden (Figs. 8 and 9) and in future mortality rela-
tive to 2000 (Figs. 1 and 4), we estimate the future global
burden for two cases: Case A, using 2000 concentrations rel-
ative to 1850 and present-day population but future baseline
mortality rates; and Case B, using 2000 concentrations rel-
ative to 1850 but future population and baseline mortality
rates. Case A reflects the effect of future baseline mortality
rates on the global burden, if concentrations in future years
were maintained at 2000 levels, while Case B reflects the
combined effect of population and baseline mortality rates,
i.e., it is identical to Case A except that population changes.
The difference between the global burden for each RCP and
Case B reflects the effects of changes in future air pollutant
concentrations and nearly equals future mortality relative to
2000 concentrations in Figs. 1 and 4. However, cases A and
B are calculated for all 14 models for ozone and 6 models for
PM2.5 (since all models reported air pollutant concentrations
in 2000), while future mortality relative to 2000 is calculated
for the models that report each scenario/year.
4 Discussion
In all RCP scenarios but RCP8.5, stringent air pollution con-
trols lead to substantial decreases in ozone concentrations
through the 21st century, relative to 2000. For RCP8.5, the
higher baseline GHG (including methane) and air pollutant
emissions lead to increases in future ozone concentrations.
In contrast, global PM2.5 concentrations show a decreasing
trend across all RCP scenarios. These changes in air pollutant
concentrations, combined with projected increases in base-
line mortality rates for chronic respiratory diseases, drive
ozone mortality to become more important relative to PM2.5
mortality over the next century.
The importance of conducting health impact assessments
with air pollutant concentrations from model ensembles, in-
stead of from single models, is highlighted by the differences
in sign of the change in mortality among models and by the
marked impact of the spread of model results on overall un-
certainty in our mortality estimates. In most cases assessed
here (ozone mortality in 2030 relative to 2000, PM2.5 mor-
tality in 2030, 2050 and 2100 relative to 2000), uncertainty in
modeled air pollutant concentrations is the greatest contrib-
utor to uncertainty in mortality estimates. The differences in
air pollutant concentrations reported by the ACCMIP mod-
els reflect different treatment of atmospheric dynamics and
chemistry, chemistry–climate interactions and natural emis-
sions in each model (Young et al., 2013). Although there
is likely a bias in estimating health effects using air pollu-
tant concentrations from coarse-resolution models (Li et al.,
2016; Punger and West, 2013), particularly for PM2.5, we
do not expect resolution to be an important factor for the dif-
ferences in simulated concentrations across coarse-resolution
models.
There are several uncertainties and assumptions that af-
fect our results. We applied the same RR worldwide and into
the future, despite differences in vulnerability of the exposed
population, in composition of PM2.5 and in other factors that
may support the use of different risk estimates or differ-
ent concentration–response relationships. These uncertain-
ties can be addressed through additional long-term epidemi-
ological studies, particularly for large cohorts in developing
countries, to improve RR estimates globally. These studies
should be more representative of wider ranges of exposure
and air pollutant mixtures than existing studies in the USA
and Europe, and they should control for confounding factors
such as other environmental exposures, use of air condition-
ing, socioeconomic factors, etc. Also, we estimate mortality
for adults aged 25 and older and do not quantify air pollutant
effects on morbidity, so we underestimate the overall impact
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of changes in pollutant concentrations on human health. Un-
certainty is evaluated for a single future population projec-
tion, not accounting for the wide range of projections in the
literature, and does not reflect uncertainty in baseline mor-
tality rates, as these are not reported; uncertainties in both
population and baseline mortality rates would be expected
to increase with time into the future. The spread of model
results does not account for uncertainty in emissions inven-
tories, as all ACCMIP models used the same projections of
anthropogenic emissions. Moreover, climate and air quality
interactions and feedbacks are not sufficiently understood to
be fully reflected in modeled air pollutant concentrations,
and global models simplify atmospheric physics and chem-
ical processes. This is particularly important when model-
ing air quality given scenarios of future emissions and cli-
mate change. For example, most global models do not fully
address climate sensitivity to biogenic emissions (e.g., iso-
prene, soil NOx and methane) and stratosphere–troposphere
interactions (e.g., stratospheric influx of ozone). A better un-
derstanding of aerosol–cloud interactions, of the impact of
climate change on wildfires and of the impact of land use
changes on regional climate and air pollution is also crucial.
Our results are limited by the range of air pollutant emis-
sions projected by the RCPs, which assume that economic
growth strengthens efforts to reduce air pollution emis-
sions. All RCPs project reductions in anthropogenic precur-
sor emissions associated with more extensive air quality leg-
islation as incomes rise, except for methane in RCP8.5 and
for ammonia in all scenarios. These scenarios together do
not encompass the range of plausible air pollution futures for
the 21st century, as the RCPs were not designed for this pur-
pose (van Vuuren et al., 2011a). Other plausible scenarios
have been considered, such as the Current Legislation Emis-
sions and Maximum Feasible Reductions scenarios used by
Likhvar et al. (2015) and the Business-As-Usual scenario of
Lelieveld et al. (2015). As noted above, our global burden
estimates for 2050 are considerably lower than the Business-
As-Usual scenario of Lelieveld et al. (2015). If economic
growth does not lead to stricter air pollution control, emis-
sions and health effects may rise considerably, particularly
for scenarios of high population growth in developing coun-
tries (Amman et al., 2013).
5 Conclusions
Under the RCP scenarios, future PM2.5 concentrations lead
to decreased global premature mortality vs. what would oc-
cur with fixed year-2000 concentrations, but ozone-related
mortality increases in some scenarios/periods. In 2100, ex-
cess ozone-related premature mortality for RCP8.5 is es-
timated to be 316 thousand (−187 thousand to 1.38 mil-
lion) deaths year−1 (likely due to an increase in methane
emissions and to the net effect of climate change), while
for the three other RCPs avoided ozone mortality is between
−718 thousand and −1.02 million deaths year−1. For PM2.5,
avoided future premature mortality is estimated to be be-
tween−1.33 and−2.39 million deaths year−1 in 2100. These
reductions in ambient air-pollution-related mortality reflect
the decline in pollutant emissions projected in the RCPs, but
the large range of results from the four RCPs highlights the
importance of future air pollutant emissions for ambient air
quality and global health. Mortality estimates differ among
models and we find that, for most cases, the contribution to
overall uncertainty from uncertainty associated with modeled
air pollutant concentrations exceeds that from the RRs. In-
creases in exposed population and in baseline mortality rates
of respiratory diseases magnify the impact on mortality of
the changes in air pollutant concentrations.
Estimating future mortality relative to 2000 concentrations
allows us to emphasize the effects of changes in air pollu-
tion in these results. However, increases in exposed popu-
lation and in baseline mortality rates may drive an increase
in the future burden of air pollution on mortality. Even in
the most optimistic scenarios, the global mortality burden
of ozone (relative to 1850 concentrations) is estimated to
be over 1 million deaths year−1 in 2100, compared to less
than 0.4 million in 2000. For PM2.5, the global burdens
in 2030 and 2050 for the four RCPs are greater than the
global burden in 2000 but decrease to between 0.56 and
1.55 million deaths year−1 in 2100, compared to 1.7 mil-
lion deaths year−1 in 2000. A strong decline in PM2.5 con-
centrations for all RCPs together with demographic trends
in the 21st century (with a projected substantial increase in
exposed population) lead to a rising importance of ozone rel-
ative to PM2.5 for the global burden of ambient air-pollution-
related mortality.
The RCPs are based on the premise that economic de-
velopment drives better air pollution control, leading to im-
proved air quality. This trend is apparent in some developing
countries now (Klimont et al., 2013), but it is yet to be deter-
mined how aggressive many developing nations will be in ad-
dressing air pollution. The assumed link between economic
development and air pollution control in the RCPs requires
new and stronger regulations around the world, as well as
new control technologies, for the air pollution decreases in
the RCPs to be realized. The projected reductions in mor-
tality estimated here will be compromised if more stringent
policies are delayed (e.g., Lelieveld et al., 2015).
6 Data availability
Air pollutant concentrations are available from Atmo-
spheric Chemistry & Climate Model Intercomparison
Project (ACCMIP) datasets at http://catalogue.ceda.ac.uk/
uuid/b46c58786d3e5a3f985043166aeb862d. Data were re-
trieved from 08/2012 to 12/2013.
Present-day population data are available from the Oak
Ridge National Laboratory (ONRL) LandScan 2011 Global
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Population Dataset at http://spruce.lib.unc.edu.libproxy.lib.
unc.edu/content/gis/LandScan/. Data were retrieved on
12/05/2012.
Present-day baseline mortality data are available from the
Institute for Health Metrics and Evaluation (IHME) Global
Burden of Disease Study 2010 (GBD 2010): Results by
Cause 1990–2010 – Country Level, Seattle, United States,
2013, at https://cloud.ihme.washington.edu/index.php/s/
d559026958b38c3f4d12029b36d783da?path=/2010. Data
were retrieved from 12/2013 to 03/2014.
Future population and baseline mortality data are avail-
able from the web-based International Futures (IFs) model-
ing system, version 6.54, at www.ifs.du.edu. Data were re-
trieved on 07/2012.
IER model data are available from the Institute for
Health Metrics and Evaluation (IHME) Global Bur-
den of Disease Study 2010: Global Burden of Disease
Study 2010 (GBD 2010) – Ambient Air Pollution Risk
Model 1990–2010, Seattle, United States, 2013, at
http://ghdx.healthdata.org/record/global-burden-disease-
study-2010-gbd-2010-ambient-air-pollution-risk-model-
1990-2010. Data were retrieved on 11/08/2013.
The Supplement related to this article is available online
at doi:10.5194/acp-16-9847-2016-supplement.
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